GTR 72848743
Bids Are Invited For Injectable Oncology Medications
ICB — International Competitive Bid
Closed
South America
Tender Information
GTR Reference
72848743
Tendering Authority
Subscribe to view
Tender No
00272/2023
Financer Name
Self-Funded
Work Title
Bids Are Invited For Injectable Oncology Medications
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
South America
Political Region
BRIC,G20
Last Date of Bid Submission
04-12-2023
Closed
Work Detail
Patent Blue, Bleomycin Sulfate, Bortezomib, Carboplatin, Cyclophosphamide, Cisplatin, Cytarabine, Dacarbazine, Daunorubicin, Docetaxel, Doxorubicin Hydrochloride, Epirubicin Hydrochloride, Chemical Compound, Filgrastim, Fludarabine Phosphate, Fluoruracil, Fulvestrant, Gemcitabine Hydrochloride, Goserelin Acetate, Idarubicin Hydrochloride, Ifosfamide , Irinotecan Hydrochloride, Mesna, Methotrexate, Mitoxantrone Hydrochloride, Oxaliplatin, Paclitaxel, Pegaspargase, Trastuzumab, Rituximab, Topotecan Hydrochloride, Vinblastine, Vincristine, Vinorelbine, Vaccine, Calcium Folinate, Lanreotide Acetate, Octreotide
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
d9f58b07-522d-4e53-9c33-a5255a8b7c03.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.